Track record · closed signal

Vericel Corp Ord (VCEL) — closed signal from May 18, 2026

Target reached Published before the outcome was known, scored automatically when the window closed on August 16, 2026 — +29.7% at the close.

Predicted vs. what happened

VCEL price · publication thesis → realized outcomesplit-adjusted
$34.08 Published $40.90 Target $44.20 Window close $49.32 Peak
$32.75 – $34.50Entry zone — fair-value band
$34.08Published — price the day we called it
$40.90Target — the price the thesis aimed for
$49.32Peak — highest point inside the window, not a realized return
$44.20Window close — end-of-window price, context only

What happened

Target reached

Reached its target in 35 days.

At window close
+29.7%
realized, from the publication price to the last close inside the window
Peak gain
+44.7%
peak, from the publication price — not a realized return
S&P 500, same window
+5.4%
SPY over the identical days, dividend-adjusted
Window close
$44.20
last close inside the window, ended August 16, 2026
Peak price
$49.32
peak on July 30, 2026 — not a realized return
Days to target
35

The thesis — published May 18, 2026

Predicted growth
+20%
over the measurement window
Target price
$40.90
the price the thesis aimed for
Entry zone
$32.75 – $34.50
the fair-value band we waited for
Price at publication
$34.08
published May 18, 2026
Confidence
68%
how strongly the data lined up
Timeframe
Short-term (0–3 months)

Vericel raised its outlook and reported stronger sales, which makes the company's growth story more believable. A recent sharp drop in price could reset expectations and create a clearer opportunity, but trading is thin and the stock is risky with a high valuation. Overall, the upside looks sizable but fragile.

Primary drivers

  • Guidance raise shows the business is gaining traction
  • Stronger sales signal wider adoption of therapies
  • Analyst estimate changes help near-term sentiment
  • Pullback offers a contained chance for a rebound

How it played out

VCEL: target reached in 35 days

Lyra published VCEL at $34.08 with an expected gain of 20% and a target of $40.90. The thesis pointed to raised guidance, stronger sales, analyst estimate changes, and a recent pullback as support for a rebound. It also noted thin trading, high valuation, and fragile upside.

The price reached the target in 35 days. It later peaked at $49.32 on July 30, a gain of 44.7%. VCEL ended the window at $44.20, still above the target. The thesis played out and exceeded its published price objective.

What happened during the window

On July 30, 2026, Vericel reported second-quarter revenue of $77.5 million, up 22%. The company also raised its full-year revenue guidance to $330 million to $340 million and announced a $200 million share repurchase program.

Prices are shown split- and dividend-adjusted, matching what public charts show today.

Share this receipt

A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.

Lyra

Read the next call before it closes.

This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.

See today’s picks All VCEL signals